A detailed history of Ogorek Anthony Joseph transactions in Novo Nordisk A S stock. As of the latest transaction made, Ogorek Anthony Joseph holds 340 shares of NVO stock, worth $16,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares
340
Holding current value
$16,476
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 23, 2026

BUY
$45.68 - $59.65 $15,531 - $20,281
340 New
340 $17,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ogorek Anthony Joseph Portfolio

Follow Ogorek Anthony Joseph and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

News

Stay updated on Ogorek Anthony Joseph with notifications on news.